Interv Akut Kardiol. 2003;2(4):190-197

QUANTITATIVE EVALUATION OF MYOCARDIAL PERFUSION, FUNCTION AND VIABILITY USING SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY

Milan Kamínek, Miroslav Mysliveček, Václav Hušák
Klinika nukleární medicíny FN a LF UP v Olomouci

A review is given about the present state of nuclear cardiology, particularly about the progress in single photon emission computed tomography (SPECT). ECG-gated SPECT examination is a current standard which makes possible the evaluation of left ventricular (LV) myocardial perfusion and function. A spectrum of patients referred for this examination changes significantly. Myocardial perfusion SPECT plays the important role in diagnostics of coronary artery disease (CAD), however, there is nowadays growing significance of the evaluation of prognosis in patients known or suspected CAD, detection of ischemia CAD in some patients after coronary revascularization, and viability assessment in patients with LV dysfunction. Quantification of the extent and severity of perfusion defects by means of a summed stress score (SSS) yields important information on decision concerning further therapy. In patients with the normal perfusion (SSS 0–3) or with the mildly abnormal perfusion (SSS 4–8) the risk of heart death is low (< 1 % annually) and medicamentous therapy can be preferred. On the contrary, in patients with the moderate or severe abnormality of perfusion (SSS > 8) preference is given to the invasive strategy.

Keywords: myocardial perfusion, gated SPECT, coronary artery disease, risk stratification.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kamínek M, Mysliveček M, Hušák V. QUANTITATIVE EVALUATION OF MYOCARDIAL PERFUSION, FUNCTION AND VIABILITY USING SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY. Interv Akut Kardiol. 2003;2(4):190-197.
Download citation

References

  1. Niederle P. Hodnocení viability myokardu - stále aktuální problém. Cor Vasa 2002; 44: 166-167.
  2. Tamaki N, Yonekura Y, Mukai T, et al. Stress thallium-201 transaxial computed tomography: Quantitative versus qualitative analysis for evaluation of coronary artery disease. J Am Coll Cardiol 1984; 4: 1213-1221. Go to original source... Go to PubMed...
  3. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990; 15: 318-329. Go to original source... Go to PubMed...
  4. DePasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988; 77: 316-327. Go to original source... Go to PubMed...
  5. Brown KA. Prognostic Value of a Nuclear Cardiology Techniques. In: Gerson MC. Cardiac Nuclear Medicine. 3rd edition, New York: McGraw Hill, 1997: 619-654.
  6. Meluzín J. Postavení zátěžových testů v diagnostice nemoci koronárních tepen a při posuzování její prognózy. Cor Vasa 1997; 39: 44-49, 105-110.
  7. Kósa I, Blasini R, Schneider-Eicke J, et al. Myocardial Perfusion Scintigraphy to Evaluate Patients After Coronary Stent Implantation. J Nucl Med 1998; 39: 1307-1311. Go to PubMed...
  8. Milan E, Zoccarato O, Terzi A, Ettori F, Leonzi O, Niccoli L, Giubbini R. Technetium- 99m-sestamibi SPECT to detect restenosis after successful percutaneous coronary angioplasty. J Nucl Med 1996; 37: 1300-1305. Go to PubMed...
  9. Strauss HW, Miller DD, Wittry MD, et al. Procedure Guideline for Myocardial Perfusion Imaging. J Nucl Med 1998; 39: 918-923. Go to PubMed...
  10. Klocke FJ, Baird MG, Beverly HL, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging - Executive Summary. Circulation 2003; 108: 1404-1418. Go to original source... Go to PubMed...
  11. Underwood SR, Godman B, Salyani S, Ogle J, Ell PJ. Economics of Myocardial Perfusion Imaging in Europe - The Empire Study. Eur Heart J 1999; 20: 157-166. Go to original source... Go to PubMed...
  12. Levin DC, Parker L, Intenzo CHM, Sunshine JH. Recent Rapid Increase in Utilization of Radionuclide Myocardial Perfusion Imaging and Related Procedures: 1996-1998 Practise Patterns. Radiology 2002; 222: 144-148. Go to original source... Go to PubMed...
  13. Kamínek M, Hušák V, Mysliveček M, Lang O. Activity and Practice of Nuclear Cardiology in the Czech Republic 2001. Eur J Nucl Med 2003; 30 (2): 321-324. Go to original source... Go to PubMed...
  14. Prvulovich E, Metcalfe MJ. Nuclear cardiology in the UK: activity and practice 1997. Eur J Nucl Med 2002; 29: 553-558. Go to original source... Go to PubMed...
  15. Hachamovitch R. Clinical value of combined perfusion and function imaging in the diagnosis, prognosis, and management of patients with suspected or known coronary artery disease. In: Germano G, Berman DS. Clinical gated cardiac SPECT, Armonk, New York: Futura Publishing Company, Inc., 1999: 239-258.
  16. Taillefer, R., Tamaki, N. New Radiotracers in Cardiac Imaging. Principles and Applications. Stamford - Connecticut, USA. Appleton & Lange, 1999.
  17. Kamínek M, Mysliveček M, Hušák V, Kubinyi J, Lang O, Záhlava J. Metody zátěže používané v nukleární kardiologii. Cor Vasa 2000; 42 (1): 40-46.
  18. Mysliveček M, Kamínek M. Doporučení k provádění zátěžových testů v nukleární kardiologii. Cor Vasa 2000; 42 (3): K54-56.
  19. Follansbee WP. Alternatives to Leg Exercise in the Evaluation of Patients with Coronary Artery Disease: Functional and Pharmacologic Stress Modalites. In: Gerson MC. Cardiac Nuclear Medicine. 3rd ed. New York: McGraw-Hill, 1997: 193-235.
  20. Cosín-Sales J, Maceira AM, García-Velloso MJ, Macías A, Gimenez M, García-Bolao I, a spol. Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosdis of myocardial ischemia. J Nucl Cardiol 2002; 9: 581-586. Go to original source... Go to PubMed...
  21. De Lorenzo A, Foerster J, Sciammarella MG,Suey C, Hayes SW, Friedman J,D, et al. Use of atropine in patients with submaximal heart rate during exercise myocardial perfusion SPECT. J Nucl Cardiol 2003; 10: 51-55. Go to original source... Go to PubMed...
  22. Diamond GA, Forrester JS. Analysis of probabilty as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979; 300: 1350-1358. Go to original source... Go to PubMed...
  23. Van Train KF, Garcia EV, Maddahi J, et al. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 1994; 35: 609-618. Go to PubMed...
  24. Bachmann R, Sechtem U, Voth E, Schröder J, Hö pp.HW, Schicha H. Dipyridamole Scintigraphy and Intravascular Ultrasound After Successful Coronary Intervention. J Nucl Med 1997; 38: 553-558. Go to PubMed...
  25. Gerson MC. Tets Accuracy, Test Selection, and Test Result Interpretation in Chronic Coronary Artery Disease. Gerson MC. In: Cardiac Nuclear Medicine. 3/e. New York: McGraw-Hill,1997: 527-579.
  26. Kamínek M, Mysliveček M, Škvařilová M, Hušák V, Lang O. Neinvazivní detekce ischemické choroby srdeční zobrazením myokardiální perfúze - srovnání fyzické zátěže a infuze dipyridamolu. Cor Vasa 1999; 41 (4): 180-185.
  27. Casanova R, Patroncini A, Guidalotti PL, et al. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated myocardial infarction. Am J Cardiol 1992; 70: 1402-1406. Go to original source... Go to PubMed...
  28. Santana-Boado C, Candell-Riera J, Castell-Conesa, et al. Diagnostic Accuracy of Technetium-99m-MIBI Myocardial SPECT in Women and Men. J Nucl Med 1998; 39: 751-755. Go to PubMed...
  29. Azzarelli S, Galassi AR, Foti R, et al. Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease. J Nucl Cardiol 1999; 6 (2): 183-189. Go to original source... Go to PubMed...
  30. Iskandrian AS, Heo J, Nguyen T, et al. Assessment of coronary artery disease using single -photon emission computed tomography with thallium-201 during adenosine -induced coronary hyperemia. Am J Cardiol 1991; 67: 1190-1194. Go to original source... Go to PubMed...
  31. Lisbona R, Linh L, Derbekyan V, Novales-Diaz JA. Supine and Prone SPECT Tc-99m MIBI Myocardial Perfusion Imaging for Dipyridamol Studies. Clin Nucl Med 1995; 20: 674-677. Go to original source... Go to PubMed...
  32. Francisco DA, Collons SM, Go RT, et al. Tomographic thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilation with dipyridamole: Comparison of qualitative and quantitative approaches. Circulation 1982; 66: 370-379. Go to original source... Go to PubMed...
  33. Huikuri HV, Korhonen UR, Airaksinen J, et al. Comparison of dipyridamole -handgrip test and bicycle exercise test for thallium tomographic imaging. Am J Cardiol 1988; 61: 264-268. Go to original source... Go to PubMed...
  34. Nguyen T, Heo J, Ogilby JD, et al. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary angiography, exercise thallium imaging and two-dimensional echocarrdiography. J Am Coll Cardiol 1990; 16: 1375-1383. Go to original source... Go to PubMed...
  35. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93 (5): 905-914. Go to original source... Go to PubMed...
  36. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97 (6): 535-543. Go to original source... Go to PubMed...
  37. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002; 9: 240-245. Go to original source... Go to PubMed...
  38. Hachamovitch R, Berman DS, Lewin H, et al. Incremental prognostic value of gated SPECT ejection fraction in patients undergoing dual isotope exercise or adenosine stress SPECT. J Nucl Med 1998; 39: 101P. Go to original source...
  39. Sharir T, Geramano G, Kavangh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-1042. Go to original source... Go to PubMed...
  40. Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Fuat D, Abdel-Dayem HM. Transient postischemic stunning evaluation by stress gated Tl-201 SPECT myocardial imaging: effect on systolic left ventricular function. J Nucl Cardiol 2002; 9: 482-490. Go to original source... Go to PubMed...
  41. Sharir T, Bacher-Stier C, Dhar S, et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol. 2000; 86 (11): 1171-1175. Go to original source... Go to PubMed...
  42. Yamagishi H, Shirai N, Yoshiyama M, et al. Incremental value of left ventricular ejection fraction for detection of multivessel coronary artery disease in exercise 201Tl gated myocardial perfusion imaging. J Nucl Med 2002; 43: 131-139. Go to PubMed...
  43. Shirai N, Yamagishi H, Yoshiyama M, et al. Incremental value of regional wall motion for for detection of multivessel coronary artery disease in exercise 201Tl gated myocardial perfusion imaging. J Nucl Med 2002; 43: 443-450. Go to PubMed...
  44. Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can afect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648. Go to original source... Go to PubMed...
  45. Paul AK, Hasegawa S, Yoshioka J, et al. Exercise-induced stunning continues for at least one hour: evaluation with quantitative gated single-photon emission tomography. Eur J Nucl Med 1999; 26: 410-415. Go to original source... Go to PubMed...
  46. Marcassa CC, Campini R, Calza P, Galli M, Terazzi A, Maugeri S. Evolution of nuclear cardiology: its role in the current clinical practice. J Nucl Cardiol 2003; 10: S44.
  47. Dilsizian V. Myocardial Viability: A Clinical and Scientific Treatise. Armonk, New-York, Futura Publishing Company, Inc. 2000.
  48. Wackers FJTh, Brown KA, heller GA, Kontos MC, Tatum JL, Udelson JA, et al. American Socienty of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or ches pain center. J Nucl Cardiol 2002; 9: 46-50. Go to original source... Go to PubMed...
  49. Gerson MC, Hoit BD. Comparison of stress myocardial perfusion imaging and stress echocardiography in assessment of coronary artery disease. In: Gerson, M. C.: Cardiac Nuclear Medicine, Third edition, New York: McGraw-Hill, 1997: 581-607.
  50. Bax JJ, Poldermans D, Schinkel AF, Boersma E, Elhendy A, Maat A, et al. Perfusion and contractile reserve in chronic dysfunctional myocardium: relation to functional outcome after surgical revascularization. Circulation. 2002; 106: I14-18. Go to original source... Go to PubMed...
  51. Bax JJ, Maddahi J, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med. 2002; 43: 795-802. Go to PubMed...
  52. Kamínek M, Škvařilová M, Ostřanský J, et al. Transient postischemic stunning evaluation by gated SPECT has the potential to detect patients with multivessel coronary artery disease: Validation of the 4D-MSPECT software. Eur J Nucl Med 2003; 30 (Suppl.): S254.
  53. Kamínek M, Lang O, Hušák V, Mysliveček M. Atlas nukleární kardiologie. Praha, Lacomed spol s r.o., 2003, 34.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.